{
  "paper_id": "PMC7770442",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770442/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Fig. 1.",
      "caption": "Adjusted hazard ratios (aHR) of breast cancer incidence in women with benign breast disease compared with women with negative screening tests.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/b7bb4fb8a0bb/gr1.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/b7bb4fb8a0bb/gr1.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/b7bb4fb8a0bb/gr1.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/b7bb4fb8a0bb/gr1.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/b7bb4fb8a0bb/gr1.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7770442/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/b7bb4fb8a0bb/gr1.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Fig. 2.",
      "caption": "Adjusted hazard ratios (aHR) of breast cancer incidence in women with benign breast disease compared with women with negative screening tests testing the combined effect of type of benign breast disease, and round at benign breast disease diagnosis.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/981702b0ae40/gr2.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/981702b0ae40/gr2.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/981702b0ae40/gr2.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/981702b0ae40/gr2.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/981702b0ae40/gr2.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7770442/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/981702b0ae40/gr2.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Fig. 3.",
      "caption": "Adjusted survival curves for breast cancer incidence based on Cox proportional hazards model for women with benign breast disease vs women with negative screening tests. Fig. 3 a. Solid line represents negative screening test group; dashed line represents benign breast disease diagnosed at prevalent round, dotted line benign breast disease diagnosed in incident round. Fig. 3 b. Solid line represents negative screening test group; dashed line represents nonproliferative benign breast disease, dashdotted line represent proliferative benign breast disease without atypia, dotted line represents proliferative benign breast disease with atypia.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/425c999f8c29/gr3.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/425c999f8c29/gr3.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/425c999f8c29/gr3.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/425c999f8c29/gr3.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig3",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/425c999f8c29/gr3.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7770442/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/425c999f8c29/gr3.jpg"
    },
    "figure_4": {
      "figure_number": "Figure 4",
      "title": "Fig. 4.",
      "caption": "Adjusted survival curves for breast cancer incidence based on Cox proportional hazards model for women with benign breast disease vs women with negative screening tests.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/7fa636f71b0e/gr4.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/7fa636f71b0e/gr4.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/7fa636f71b0e/gr4.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/7fa636f71b0e/gr4.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig4",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/7fa636f71b0e/gr4.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7770442/images/figure_4.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21d/7770442/7fa636f71b0e/gr4.jpg"
    }
  },
  "claims": [
    {
      "sentence": "The highest risk was found in women with proliferative benign breast disease with atypia (aHR, 3.82; 95%CI: 2.23–6.56), followed by those with proliferative benign breast disease without atypia (aHR, 3.19; 95%CI: 2.46–4.13) and those with non-proliferative benign breast disease (aHR, 1.95; 95%CI: 1.68–2.27) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nAdjusted hazard ratios (aHR) of breast cancer incidence in women with benign breast disease compared with women with negative screening tests.The hazard ratios associated within each combination of screening type and benign breast disease subtype are shown in Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Among benign breast disease subtypes, the highest probability of cancer was found in women with a proliferative benign breast disease with atypia followed by those with proliferative benign breast disease without atypia and those with a non-proliferative benign breast disease (average 10-year breast cancer probability 6.9%, 5.8% and 3.6%, respectively) (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The highest probability was found in women with proliferative benign breast disease diagnosed in an incident screen, with an average 10-year probability of breast cancer of 7.8% (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Solid line represents negative screening test group; dashed line represents nonproliferative benign breast disease, dashdotted line represent proliferative benign breast disease without atypia, dotted line represents proliferative benign breast disease with atypia.Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The highest risk was found in women with proliferative benign breast disease with atypia (aHR, 3.82; 95%CI: 2.23–6.56), followed by those with proliferative benign breast disease without atypia (aHR, 3.19; 95%CI: 2.46–4.13) and those with non-proliferative benign breast disease (aHR, 1.95; 95%CI: 1.68–2.27) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nAdjusted hazard ratios (aHR) of breast cancer incidence in women with benign breast disease compared with women with negative screening tests.The hazard ratios associated within each combination of screening type and benign breast disease subtype are shown in Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Among benign breast disease subtypes, the highest probability of cancer was found in women with a proliferative benign breast disease with atypia followed by those with proliferative benign breast disease without atypia and those with a non-proliferative benign breast disease (average 10-year breast cancer probability 6.9%, 5.8% and 3.6%, respectively) (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The highest probability was found in women with proliferative benign breast disease diagnosed in an incident screen, with an average 10-year probability of breast cancer of 7.8% (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Solid line represents negative screening test group; dashed line represents nonproliferative benign breast disease, dashdotted line represent proliferative benign breast disease without atypia, dotted line represents proliferative benign breast disease with atypia.Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The highest risk was found in women with proliferative benign breast disease with atypia (aHR, 3.82; 95%CI: 2.23–6.56), followed by those with proliferative benign breast disease without atypia (aHR, 3.19; 95%CI: 2.46–4.13) and those with non-proliferative benign breast disease (aHR, 1.95; 95%CI: 1.68–2.27) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nAdjusted hazard ratios (aHR) of breast cancer incidence in women with benign breast disease compared with women with negative screening tests.The hazard ratios associated within each combination of screening type and benign breast disease subtype are shown in Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Among benign breast disease subtypes, the highest probability of cancer was found in women with a proliferative benign breast disease with atypia followed by those with proliferative benign breast disease without atypia and those with a non-proliferative benign breast disease (average 10-year breast cancer probability 6.9%, 5.8% and 3.6%, respectively) (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The highest probability was found in women with proliferative benign breast disease diagnosed in an incident screen, with an average 10-year probability of breast cancer of 7.8% (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Solid line represents negative screening test group; dashed line represents nonproliferative benign breast disease, dashdotted line represent proliferative benign breast disease without atypia, dotted line represents proliferative benign breast disease with atypia.Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The highest risk was found in women with proliferative benign breast disease with atypia (aHR, 3.82; 95%CI: 2.23–6.56), followed by those with proliferative benign breast disease without atypia (aHR, 3.19; 95%CI: 2.46–4.13) and those with non-proliferative benign breast disease (aHR, 1.95; 95%CI: 1.68–2.27) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nAdjusted hazard ratios (aHR) of breast cancer incidence in women with benign breast disease compared with women with negative screening tests.The hazard ratios associated within each combination of screening type and benign breast disease subtype are shown in Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Among benign breast disease subtypes, the highest probability of cancer was found in women with a proliferative benign breast disease with atypia followed by those with proliferative benign breast disease without atypia and those with a non-proliferative benign breast disease (average 10-year breast cancer probability 6.9%, 5.8% and 3.6%, respectively) (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The highest probability was found in women with proliferative benign breast disease diagnosed in an incident screen, with an average 10-year probability of breast cancer of 7.8% (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Solid line represents negative screening test group; dashed line represents nonproliferative benign breast disease, dashdotted line represent proliferative benign breast disease without atypia, dotted line represents proliferative benign breast disease with atypia.Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The highest risk was found in women with proliferative benign breast disease with atypia (aHR, 3.82; 95%CI: 2.23–6.56), followed by those with proliferative benign breast disease without atypia (aHR, 3.19; 95%CI: 2.46–4.13) and those with non-proliferative benign breast disease (aHR, 1.95; 95%CI: 1.68–2.27) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nAdjusted hazard ratios (aHR) of breast cancer incidence in women with benign breast disease compared with women with negative screening tests.The hazard ratios associated within each combination of screening type and benign breast disease subtype are shown in Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Among benign breast disease subtypes, the highest probability of cancer was found in women with a proliferative benign breast disease with atypia followed by those with proliferative benign breast disease without atypia and those with a non-proliferative benign breast disease (average 10-year breast cancer probability 6.9%, 5.8% and 3.6%, respectively) (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The highest probability was found in women with proliferative benign breast disease diagnosed in an incident screen, with an average 10-year probability of breast cancer of 7.8% (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Solid line represents negative screening test group; dashed line represents nonproliferative benign breast disease, dashdotted line represent proliferative benign breast disease without atypia, dotted line represents proliferative benign breast disease with atypia.Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The highest risk was found in women with proliferative benign breast disease with atypia (aHR, 3.82; 95%CI: 2.23–6.56), followed by those with proliferative benign breast disease without atypia (aHR, 3.19; 95%CI: 2.46–4.13) and those with non-proliferative benign breast disease (aHR, 1.95; 95%CI: 1.68–2.27) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nAdjusted hazard ratios (aHR) of breast cancer incidence in women with benign breast disease compared with women with negative screening tests.The hazard ratios associated within each combination of screening type and benign breast disease subtype are shown in Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Among benign breast disease subtypes, the highest probability of cancer was found in women with a proliferative benign breast disease with atypia followed by those with proliferative benign breast disease without atypia and those with a non-proliferative benign breast disease (average 10-year breast cancer probability 6.9%, 5.8% and 3.6%, respectively) (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The highest probability was found in women with proliferative benign breast disease diagnosed in an incident screen, with an average 10-year probability of breast cancer of 7.8% (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Solid line represents negative screening test group; dashed line represents nonproliferative benign breast disease, dashdotted line represent proliferative benign breast disease without atypia, dotted line represents proliferative benign breast disease with atypia.Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The highest risk was found in women with proliferative benign breast disease with atypia (aHR, 3.82; 95%CI: 2.23–6.56), followed by those with proliferative benign breast disease without atypia (aHR, 3.19; 95%CI: 2.46–4.13) and those with non-proliferative benign breast disease (aHR, 1.95; 95%CI: 1.68–2.27) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nAdjusted hazard ratios (aHR) of breast cancer incidence in women with benign breast disease compared with women with negative screening tests.The hazard ratios associated within each combination of screening type and benign breast disease subtype are shown in Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Among benign breast disease subtypes, the highest probability of cancer was found in women with a proliferative benign breast disease with atypia followed by those with proliferative benign breast disease without atypia and those with a non-proliferative benign breast disease (average 10-year breast cancer probability 6.9%, 5.8% and 3.6%, respectively) (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The highest probability was found in women with proliferative benign breast disease diagnosed in an incident screen, with an average 10-year probability of breast cancer of 7.8% (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Solid line represents negative screening test group; dashed line represents nonproliferative benign breast disease, dashdotted line represent proliferative benign breast disease without atypia, dotted line represents proliferative benign breast disease with atypia.Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The highest risk was found in women with proliferative benign breast disease with atypia (aHR, 3.82; 95%CI: 2.23–6.56), followed by those with proliferative benign breast disease without atypia (aHR, 3.19; 95%CI: 2.46–4.13) and those with non-proliferative benign breast disease (aHR, 1.95; 95%CI: 1.68–2.27) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nAdjusted hazard ratios (aHR) of breast cancer incidence in women with benign breast disease compared with women with negative screening tests.The hazard ratios associated within each combination of screening type and benign breast disease subtype are shown in Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Among benign breast disease subtypes, the highest probability of cancer was found in women with a proliferative benign breast disease with atypia followed by those with proliferative benign breast disease without atypia and those with a non-proliferative benign breast disease (average 10-year breast cancer probability 6.9%, 5.8% and 3.6%, respectively) (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The highest probability was found in women with proliferative benign breast disease diagnosed in an incident screen, with an average 10-year probability of breast cancer of 7.8% (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Solid line represents negative screening test group; dashed line represents nonproliferative benign breast disease, dashdotted line represent proliferative benign breast disease without atypia, dotted line represents proliferative benign breast disease with atypia.Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The highest risk was found in women with proliferative benign breast disease with atypia (aHR, 3.82; 95%CI: 2.23–6.56), followed by those with proliferative benign breast disease without atypia (aHR, 3.19; 95%CI: 2.46–4.13) and those with non-proliferative benign breast disease (aHR, 1.95; 95%CI: 1.68–2.27) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nAdjusted hazard ratios (aHR) of breast cancer incidence in women with benign breast disease compared with women with negative screening tests.The hazard ratios associated within each combination of screening type and benign breast disease subtype are shown in Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Among benign breast disease subtypes, the highest probability of cancer was found in women with a proliferative benign breast disease with atypia followed by those with proliferative benign breast disease without atypia and those with a non-proliferative benign breast disease (average 10-year breast cancer probability 6.9%, 5.8% and 3.6%, respectively) (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The highest probability was found in women with proliferative benign breast disease diagnosed in an incident screen, with an average 10-year probability of breast cancer of 7.8% (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Solid line represents negative screening test group; dashed line represents nonproliferative benign breast disease, dashdotted line represent proliferative benign breast disease without atypia, dotted line represents proliferative benign breast disease with atypia.Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The highest risk was found in women with proliferative benign breast disease with atypia (aHR, 3.82; 95%CI: 2.23–6.56), followed by those with proliferative benign breast disease without atypia (aHR, 3.19; 95%CI: 2.46–4.13) and those with non-proliferative benign breast disease (aHR, 1.95; 95%CI: 1.68–2.27) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The hazard ratios associated within each combination of screening type and benign breast disease subtype are shown in Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Among benign breast disease subtypes, the highest probability of cancer was found in women with a proliferative benign breast disease with atypia followed by those with proliferative benign breast disease without atypia and those with a non-proliferative benign breast disease (average 10-year breast cancer probability 6.9%, 5.8% and 3.6%, respectively) (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The highest probability was found in women with proliferative benign breast disease diagnosed in an incident screen, with an average 10-year probability of breast cancer of 7.8% (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 4,
    "claims_count": 49,
    "images_downloaded": 4,
    "tables_filtered": 10
  }
}